Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-pr opyl)phenol and providing delayed release of the active ingredient

Details for Australian Patent Application No. 2002349001 (hide)

Owner Gruenenthal GmbH

Inventors Ziegler, Iris; Bartholomaus, Johannes

Agent Spruson & Ferguson

Pub. Number AU-B-2002349001

PCT Number PCT/EP02/11809

PCT Pub. Number WO2003/035053

Priority 101 52 469.2 24.10.01 DE; 102 48 309.4 16.10.02 DE

Filing date 22 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 19 April 2007

International Classifications

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 101 52 469.2 24.10.01 DE; 102 48 309.4 16.10.02 DE

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002349001

19 April 2007 Application Accepted

  Published as AU-B-2002349001

16 August 2007 Standard Patent Sealed

12 May 2011 Extension of Term of Standard Patents

  Gruenenthal GmbH The earliest first regulatory approval date provided by the patentee 19 Jan 2011 For the goods Palexia PR tapentadol

26 May 2011 Extension of Term of Standard Patents

  Gruenenthal GmbH The earliest first regulatory approval date provided by the patentee 19 Jan 2011 For the goods Palexia PR tapentadol Address for service in Australia: Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

27 October 2011 Extension granted

  Gruenenthal GmbH The earliest first regulatory approval date provided by the patentee 19 Jan 2011 For the goods Palexia PR tapentadol Extension of Term of patent pursuant to Section 77 expires on 22 Oct 2022

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002349002-SUBSTITUTED BENZO(B)AZEPIN-2-ONE COMPOUNDS

2002349000-RACK